Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00541_DB06145_nanopub.RAWq2cpbACZ7ksoU--LZWGe9LL8z0AgfNM7qxOn8KoeQQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00541_DB06145 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00541_DB06145 label "DDI between Vincristine and Spiramycin - Spiramycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vincristine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Spiramycin is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB06145]" assertion.
- drugbank_resource:DB00541_DB06145 identifier "drugbank_resource:DB00541_DB06145" assertion.
- drugbank_resource:DB00541_DB06145 title "DDI between Vincristine and Spiramycin - Spiramycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vincristine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Spiramycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00541 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00541_DB06145 assertion.
- drugbank:DB06145 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00541_DB06145 assertion.